Type 2 Diabetes Mellitus With HypoglycemiaNCT05263310
Prepare for Your Diabetes Care
A study testing Prepare for Your Diabetes Care in people with Type 2 Diabetes Mellitus With Hypoglycemia and Aging, run by Kaiser Permanente at 1 site in United States.
Trial summary
As adults with type 2 diabetes age, they are increasingly vulnerable to treatment-related hypoglycemia and its related complications (including hospitalization and death). This study proposes to evaluate, in a randomized clinical trial, a strategy of expanded advance care planning to support older adults in… Read more about this study
- Who is it for?
- Ages 75 years and older
- Conditions the study is for
- Type 2 Diabetes Mellitus With Hypoglycemia, Aging, Patient Activation
- What is being tested?
- Prepare for Your Diabetes Care
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 672 participants
- Where
- 1 siteUnited States
- Study dates
- 25 Apr 2022to 8 Aug 2025
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 75 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- Age ≥ 75 years
- Type 2 diabetes with last measured HbA1c ≤ 8.0%
- Currently prescribed insulin and/or SUs
- Kaiser Permanente Northern California member
Who cannot join
- Unable to communicate in English
- Unable to provide informed consent and/or participate in informed decision making due to cognitive or communication-related deficits
- Excluded by their primary care provider
Trial locations and contacts
1 site in 1 country.
United States1 site
Kaiser Permanente - Oakland Medical Center
Oakland, California, 94577
About this study
Official title: Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
As adults with type 2 diabetes age, they are increasingly vulnerable to treatment-related hypoglycemia and its related complications (including hospitalization and death). This study proposes to evaluate, in a randomized clinical trial, a strategy of expanded advance care planning to support older adults in value-aligned re-assessment of diabetes treatment regimens with their primary care team. If the aims of this project are achieved and incidence of clinically-significant hypoglycemia is reduced, this Prepare for Your Diabetes web-based patient educational care strategy could be scaled and applied in a wide variety of healthcare settings and chronic conditions in which evolving risks, benefits, and consequences of treatment require re-assessment with age.
Read the detailed description
In this pragmatic, clinical efficacy, parallel group randomized clinical trial, the study will enroll eligible Kaiser Permanente Northern California members (age 75 years or greater, type 2 diabetes, prescribed insulin or sulfonylureas [SUs], and last measured HbA1c <=8%). Participants randomly allocated to the intervention arm will view the Prepare for Your Diabetes Care web-based educational module that is designed to help them prepare to discuss their diabetes medication regimens with their primary care providers and receive an Action Plan handout. Participants randomly allocated to the control arm will continue with usual care. All participants will complete baseline, 6-month, and 12-month surveys. The hypothesis is that empowering high-risk patients to engage in values-based discussions about diabetes treatment intensity will result - when clinically appropriate - in decreases in diabetes regimen intensity leading to decreased incidence of hypoglycemia over the 12-month study period. If successful, this study will provide evidence to support strategies for safer treatment in older adults with type 2 diabetes.
- Being tested
- Prepare for Your Diabetes Care, Usual Care
- Medical subject headings
- Patient Participation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Prepare for Your Diabetes CareBehavioural
Educational video and Action Plan handout
Usual CareBehavioural
Control arm patients will continue with usual care
| Study group | Role | What they receive |
|---|---|---|
| Educational Video and Action Plan handout | Experimental | Patients in the intervention arm will be given access to an educational video (Prepare for Your Diabetes Care) and will be supported in viewing the video and the Action Plan handout.
This program will provide brief education about changing risks and benefits of diabetes treatment as patients age, elicit values and preferences regarding treatment, and help direct next conversation steps with the participant's primary care provider. Receives: Behavioral: Prepare for Your Diabetes Care |
| Usual Care | Active comparator | Patients in the control arm will continue with usual care and also complete baseline, 6-month, and 12-month surveys Receives: Behavioral: Usual Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Any Incidence of Hypoglycemia
Any one of the following hypoglycemia event measures: 1] Self-report to survey question: Have you had three or more symptomatic hypoglycemia episodes in past 4 weeks (survey administered at month 6 and month 12); 2] Self-report to survey question: Have you had one or more severe hypoglycemia episodes in past 6 months that resulted in passing out or needing active help from someone else (survey administered at month 6 and month 12); 3 \& 4] Clinical record of any emergency department or hospital admission with primary admitting diagnosis of hypoglycemia during the 12-month study period
Measured: 12 months after baseline date
Secondary outcomes (8)
Patient-Reported Outcome: Incidence of Severe Self-Reported Hypoglycemia
Patient report of any self-reported severe hypoglycemia episodes in past 6 months that resulted in passing out or needing active help from someone else
Measured: Preceding 6-month period (asked 6 and 12 months after first study-related visit)]
Patient-Reported Outcome: Incidence of Symptomatic Self-Reported Hypoglycemia
Patient report of three or more self-reported symptomatic episodes in past 4 weeks (measured at 6- and 12-months)
Measured: Preceding 1-month period (asked 6 and 12 months after first study-related visit)
Patient-Reported Outcome: Problem Areas in Diabetes
5-item Problem Areas in Diabetes (PAID-5) + Worry about Hypoglycemia
Measured: 6 and 12 months following the first study-related visit
Clinical Utilization Outcome: Hypoglycemic-related Admissions to Emergency Department or Hospital
Hypoglycemic-related admissions in the 6 months and 12 months following the first study-related visit
Measured: 6 and 12 months following the first study-related visit
Patient-Centered Outcome: RAND Patient Satisfaction Questionnaire
5-item RAND Patient Satisfaction Questionnaire (PSQ III)
Measured: 6 and 12 months following the first study-related visit
Patient-Centered Outcome: Perceived Efficacy in Patient - Physician Interactions
5-item Perceived Efficacy in Patient - Physician Interactions (PEPPI) Survey Instrument
Measured: 6 and 12 months following the first study-related visit
Patient-Centered Outcome: Active Patient Participation During Primary Care Visits
In a subset of patients (n = 40 in each arm, total n = 80), we will audio-record a selected primary care visit. Visit transcripts will be analyzed using the Active Patient Participation Coding Scheme [Coding Instrument] and utterances per unit time [Outcome Measure] demonstrating active patient participation related to diabetes management will be compared between arms.
Measured: 6 - 12 months following the first study-related visit
Medication-Related Outcome: Aggregate Measure of Diabetes Medication Deprescribing
Aggregate measure of diabetes medication deprescribing between baseline and 12-month follow-up, defined as any combination of:
- Discontinuation of either insulin or sulfonylurea (SU),
- Reduction in dose of insulin or SU,
- Switch from a higher risk to lower risk version of insulin (e.g. from sliding scale insulin or basal-bolus insulin to twice daily basal insulin) and/or higher risk to lower risk oral medicine (e.g. switching from SU to other oral medicine less associated with hypoglycemia).
Measured: 12 months following the first study-related visit
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Mar 2022
- Study start25 Apr 2022
- Primary completion8 Aug 2025
- Study completion8 Aug 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Type 2 Diabetes Mellitus With HypoglycemiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- pragmatic, clinical efficacy, patient-level randomized clinical trial
- Masking
- Double blind
- Who is masked
- Care provider, Outcomes assessor
- Enrolment
- 672 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kaiser Permanente
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Aging (NIA)
- Responsible party
- Sponsor
- Investigators
- Richard W Grant, MD MPH, Principal investigator, Kaiser Permanente Northern California - Division of Research
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05263310
- Sponsor's protocol ID
- IRB-1635322
- Other IDs
- R01AG068133
- Status last verified
- Jun 2026
- First submitted
- 7 Feb 2022
- Last updated
- 20 Oct 2026
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Lee AK, Mejia JJ, Ferguson C, Li BH, Grant RW, Sudore RL. Expanded care planning paradigm for older adults with type 2 diabetes: Rationale, design, and protocol of the PREPARE for Your Diabetes Care randomized trial. Contemp Clin Trials. 2025 Jun;153:107913. doi: 10.1016/j.cct.2025.107913. Epub 2025 Apr 11.
PubMed 40222399
Study at a glance
From the registry record, last updated by the sponsor on 20 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
- ClinicalTrials.gov ID
- NCT05263310
- Acronym / sponsor ID
- IRB-1635322
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 672 participants (actual)
- Lead sponsor
- Kaiser PermanenteUniversity, hospital or other
- Collaborators
- National Institute on Aging (NIA)
- Study start
- 25 Apr 2022 (actual)
- Primary completion
- 8 Aug 2025 (actual)
- Study completion
- 8 Aug 2025 (actual)
- First posted
- 2 Mar 2022 (actual)
- Results
- Posted 20 Oct 2026
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
As adults with type 2 diabetes age, they are increasingly vulnerable to treatment-related hypoglycemia and its related complications (including hospitalization and death). This study proposes to evaluate, in a randomized clinical trial, a strategy of expanded advance care planning to support older adults in value-aligned re-assessment of diabetes treatment regimens with their primary care team. If the aims of this project are achieved and incidence of clinically-significant hypoglycemia is reduced, this Prepare for Your Diabetes web-based patient educational care strategy could be scaled and applied in a wide variety of healthcare settings and chronic conditions in which evolving risks, benefits, and consequences of treatment require re-assessment with age.
Detailed description
In this pragmatic, clinical efficacy, parallel group randomized clinical trial, the study will enroll eligible Kaiser Permanente Northern California members (age 75 years or greater, type 2 diabetes, prescribed insulin or sulfonylureas [SUs], and last measured HbA1c <=8%). Participants randomly allocated to the intervention arm will view the Prepare for Your Diabetes Care web-based educational module that is designed to help them prepare to discuss their diabetes medication regimens with their primary care providers and receive an Action Plan handout. Participants randomly allocated to the control arm will continue with usual care. All participants will complete baseline, 6-month, and 12-month surveys. The hypothesis is that empowering high-risk patients to engage in values-based discussions about diabetes treatment intensity will result - when clinically appropriate - in decreases in diabetes regimen intensity leading to decreased incidence of hypoglycemia over the 12-month study period. If successful, this study will provide evidence to support strategies for safer treatment in older adults with type 2 diabetes.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (care provider, outcomes assessor)
- Number of arms
- 2
- Model description
- pragmatic, clinical efficacy, patient-level randomized clinical trial
| Arm | Type | Receives |
|---|---|---|
| Educational Video and Action Plan handout | Experimental | Behavioral: Prepare for Your Diabetes CarePatients in the intervention arm will be given access to an educational video (Prepare for Your Diabetes Care) and will be supported in viewing the video and the Action Plan handout. This program will provide brief education about changing risks and benefits of diabetes treatment as patients age, elicit values and preferences regarding treatment, and help direct next conversation steps with the participant's primary care provider. |
| Usual Care | Active comparator | Behavioral: Usual CarePatients in the control arm will continue with usual care and also complete baseline, 6-month, and 12-month surveys |
Who may qualify
- Ages
- 75 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (4 listed)
- Age ≥ 75 years
- Type 2 diabetes with last measured HbA1c ≤ 8.0%
- Currently prescribed insulin and/or SUs
- Kaiser Permanente Northern California member
Key exclusion criteria (3 listed)
- Unable to communicate in English
- Unable to provide informed consent and/or participate in informed decision making due to cognitive or communication-related deficits
- Excluded by their primary care provider
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Prepare for Your Diabetes CareEducational video and Action Plan handout | Behavioural | Educational Video and Action Plan handout |
| Usual CareControl arm patients will continue with usual care | Behavioural | Usual Care |
Primary outcome
Any Incidence of Hypoglycemia
Time frame: 12 months after baseline date
Any one of the following hypoglycemia event measures: 1] Self-report to survey question: Have you had three or more symptomatic hypoglycemia episodes in past 4 weeks (survey administered at month 6 and month 12); 2] Self-report to survey question: Have you had one or more severe hypoglycemia episodes in past 6 months that resulted in passing out or needing active help from someone else (survey administered at month 6 and month 12); 3 \& 4] Clinical record of any emergency department or hospital admission with primary admitting diagnosis of hypoglycemia during the 12-month study period
8 secondary outcomes
Patient-Reported Outcome: Incidence of Severe Self-Reported Hypoglycemia
Time frame: Preceding 6-month period (asked 6 and 12 months after first study-related visit)]
Patient-Reported Outcome: Incidence of Symptomatic Self-Reported Hypoglycemia
Time frame: Preceding 1-month period (asked 6 and 12 months after first study-related visit)
Patient-Reported Outcome: Problem Areas in Diabetes
Time frame: 6 and 12 months following the first study-related visit
Clinical Utilization Outcome: Hypoglycemic-related Admissions to Emergency Department or Hospital
Time frame: 6 and 12 months following the first study-related visit
Patient-Centered Outcome: RAND Patient Satisfaction Questionnaire
Time frame: 6 and 12 months following the first study-related visit
Patient-Centered Outcome: Perceived Efficacy in Patient - Physician Interactions
Time frame: 6 and 12 months following the first study-related visit
Patient-Centered Outcome: Active Patient Participation During Primary Care Visits
Time frame: 6 - 12 months following the first study-related visit
Medication-Related Outcome: Aggregate Measure of Diabetes Medication Deprescribing
Time frame: 12 months following the first study-related visit
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Oct 2026.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Derived from this study: PubMed 40222399Lee AK, Mejia JJ, Ferguson C, Li BH, Grant RW, Sudore RL. Expanded care planning paradigm for older adults with type 2 diabetes: Rationale, design, and protocol of the PREPARE for Your Diabetes Care randomized trial. Contemp Clin Trials. 2025 Jun;153:107913. doi: 10.1016/j.cct.2025.107913. Epub 2025 Apr 11.
- Individual participant dataSharing planned: No
Related trials for Type 2 Diabetes Mellitus With Hypoglycemia
Recruiting
Changes in Person-reported Outcomes and Behavior Using the Accu-Chek SmartGuide CGM and Predict App
Diabetes (DM), Diabetes Mellitus
Not yet recruitingPhase 1/2
Study of the Safety and Efficacy of Pancreatic Endocrine Cells in Adult Patients With Type 1 Diabetes
Diabete Mellitus, Diabete Type 1
RecruitingPhase 2
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Type II Diabetes Mellitus
Not yet recruiting
Comparing Glycemic Outcomes of Carbohydrate Counting vs. Fixed Mealtime Insulin Dosing in Hospitalized Patients With Hyperglycemia
Diabetes Type 2 on Insulin, Hypoglycemia (Diabetic)
RecruitingPhase 3
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Richard W Grant, MD MPH principal investigator
Kaiser Permanente Northern California - Division of Research
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Prepare for Your Diabetes Care in people with Type 2 Diabetes Mellitus With Hypoglycemia and Aging, run by Kaiser Permanente at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 20 Oct 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Any Incidence of Hypoglycemia (time frame: 12 months after baseline date). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05263310, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2026.